CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Castle Biosciences (CSTL) Stock Sees Split Analyst Revisions As Price Targets Come Down

Negative
AI Analysis

Summary

Castle Biosciences (CSTL) faces mixed analyst revisions with multiple price target reductions. The company's stock is experiencing analyst downgrades with declining price targets from research firms.

Importance:3/10
Sentiment:
-0.40
analyst_downgradeprice_target_reductionequity_research
Related Companies

Read the original article

Published by yahoo_finance on June 26, 2026 10:07 AM

Read Original